ClearMed
All Immunology BriefingsNature Immunology
ImmunologyReal-World Cohort3 min read

A CD4-lineage erythro-myeloid progenitor within the adult bone marrow defines an alternative pathway for macrophage generation

Here we identify a previously unrecognized CD4-lineage erythro-myeloid progenitor (EMPROR) in the adult bone marrow that provides an alternative pathway for macrophage generation.

Published in Nature ImmunologyObservational cohort study
3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Source

Real-World Observation

3/5

These findings reveal an alternative pathway of adult myelopoiesis that sustains macrophage diversity beyond the classical monocyte lineage.

What Changes?

Immunology · Real-World Cohort

Current Standard

Conventional immunology practice relies on standard-of-care monitoring and existing regimens prior to this observational cohort study.

New Finding

Transcriptomic comparisons position EMPROR cells closest to embryonic erythro-myeloid progenitors, indicating the persistence of an embryonic-like program in adult bone marrow.

3 Key Takeaways

Plain English Summary
  1. 01Core Finding

    EMPROR cells are phenotypically and transcriptionally distinct from hematopoietic stem cells, common myeloid progenitors and monocyte precursors, lacking Csf1r and Ccr2 while expressing Cd4 and Kit.

  2. 02Study Evidence

    Tested in a observational cohort study at the real-world cohort stage.

  3. 03Practical Meaning

    Observational cohort findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.

What This Means for You

Transcriptomic comparisons position EMPROR cells closest to embryonic erythro-myeloid progenitors, indicating the persistence of an embryonic-like program in adult bone marrow. These findings reveal an alternative pathway of adult myelopoiesis that sustains macrophage diversity beyond the classical monocyte lineage.

The Discovery

Tissue-resident macrophages originate from distinct developmental sources, but their adult replenishment is thought to depend exclusively on circulating monocytes. Here we identify a previously unrecognized CD4-lineage erythro-myeloid progenitor (EMPROR) in the adult bone marrow that provides an alternative pathway for macrophage generation. EMPROR cells are phenotypically and transcriptionally distinct from hematopoietic stem cells, common myeloid progenitors and monocyte precursors, lacking Csf1r and Ccr2 while expressing Cd4 and Kit. Single-cell RNA sequencing, RNA velocity analysis and lineage assays reveal macrophage, neutrophil, megakaryocytic and erythroid potential. EMPROR cells generate perivascular and tumor-associated macrophages independently of CCR2-mediated monocyte recruitment and contribute to erythroid and granulocytic lineages under inflammatory and neoplastic conditions.

How It Works, Simply

This immunology research focuses on inflammation · Stem cells · Signalling pathway. Researchers evaluated it using an observational cohort study at the real-world cohort stage of medical research.

3 Key Takeaways

Clinical Takeaways
  1. 01Core Finding

    EMPROR cells are phenotypically and transcriptionally distinct from hematopoietic stem cells, common myeloid progenitors and monocyte precursors, lacking Csf1r and Ccr2 while expressing Cd4 and Kit.

  2. 02Study Evidence

    Tested in a observational cohort study at the real-world cohort stage.

  3. 03Practical Meaning

    Observational cohort findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.

01

Biological Mechanism & Study Design

Study Design & Cohort

Observational cohort study

Observational cohort study · Real-World Cohort

Biological Pathway & Modality

Inflammation · Stem cells · Signalling pathway

Intervention: A CD4-lineage erythro-myeloid progenitor within the adult bone marrow defines an

02

Experimental Findings & Endpoints

Tissue-resident macrophages originate from distinct developmental sources, but their adult replenishment is thought to depend exclusively on circulating monocytes.

Here we identify a previously unrecognized CD4-lineage erythro-myeloid progenitor (EMPROR) in the adult bone marrow that provides an alternative pathway for macrophage generation. EMPROR cells are phenotypically and transcriptionally distinct from hematopoietic stem cells, common myeloid progenitors and monocyte precursors, lacking Csf1r and Ccr2 while expressing Cd4 and Kit.

Single-cell RNA sequencing, RNA velocity analysis and lineage assays reveal macrophage, neutrophil, megakaryocytic and erythroid potential. EMPROR cells generate perivascular and tumor-associated macrophages independently of CCR2-mediated monocyte recruitment and contribute to erythroid and granulocytic lineages under inflammatory and neoplastic conditions.

03

Clinical Translation & Practice Context

Transcriptomic comparisons position EMPROR cells closest to embryonic erythro-myeloid progenitors, indicating the persistence of an embryonic-like program in adult bone marrow.

These findings reveal an alternative pathway of adult myelopoiesis that sustains macrophage diversity beyond the classical monocyte lineage.

03

The Bottom Line · Clinical Pearl

“These findings reveal an alternative pathway of adult myelopoiesis that sustains macrophage diversity beyond the classical monocyte lineage.”

Published in Nature Immunology · Current Stage: Real-World Cohort

Immunology · Real-World Cohort
Study Type
Observational cohort study

Observational cohort study

Evidence Score
3/5 · Real-World Observation
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Who It Applies To
Observational cohort study in immunology care
Intervention & Mechanism
A CD4-lineage erythro-myeloid progenitor within the adult bone marrow defines an

Inflammation · Stem cells · Signalling pathway

Key Limitation
Observational cohort findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.

Translational Stage

LEVEL 2 · Real-World Cohort

Classified as Observational cohort study along the clinical evidence continuum

  1. Lab & Discovery
  2. Early Trials
  3. Human Evidence
  4. 4Real-World CohortActive

Original Publication & AMA Citation

A CD4-lineage erythro-myeloid progenitor within the adult bone marrow defines an alternative pathway for macrophage generation. Nature Immunology. Published 2026;Nov 15. Accessed November 15, 2026. https://pubmed.ncbi.nlm.nih.gov/42934292/

Nature Immunology

https://pubmed.ncbi.nlm.nih.gov/42934292/

Read Original Paper

Continue Reading

Related in Immunology

View all Immunology briefings →
Immunology editorial photograph for Exercise Post-ACL Surgery May Prevent Early Osteoarthritis
IMMUNOLOGY · REAL-WORLD COHORT

Exercise Post-ACL Surgery May Prevent Early Osteoarthritis

Supervised exercise after ACL surgery is safe and beneficial, potentially preventing early osteoarthritis. This finding could revolutionize post-ACL surgery rehabilitation protocols, offering a safe and effective path to recovery for young adults.

3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readScienceDaily
IMMUNOLOGY · PRECLINICAL

Compartment-specific PPARδ activity controls the outcome of cancer-immune cell competition and immunotherapy efficacy

These findings identify compartment-specific PPARδ activity as a targetable driver of immune cell fitness that can be harnessed to improve outcomes in immunotherapy-resistant tumors. Therapeutically, PPARδ-activated CD8 + T cells sensitize immunotherapy-resistant microsatellite stable metastatic colorectal cancer to checkpoint blockade in mice, and pharmacological or genetic PPARδ activation enhances human chimeric antigen receptor T cell function.

2/5 Preclinical
Evidence Meter · 2/5

Animal & Preclinical Data

Demonstrated in living animal models before large-scale human safety and dosing trials begin.

1 min readNature Immunology
IMMUNOLOGY · PRECLINICAL

Evidence for maternal autoantibodies in the pathogenesis of preterm birth

These findings identify a term pregnancy humoral immune program and shared changes preceding preterm delivery, including anti-IL1RA, which may have direct pathogenic consequences. IL1RA localizes to placental endothelial (blood-vessel lining) adherens junctions, suggesting a role in vascular integrity.

3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

1 min readNature Immunology